发布求助
文献互助 智能选刊 最新文献

The Lancet最新文献

筛选
英文 中文
Surviving a migration journey and border policies in the central Mediterranean 在地中海中部的移民之旅和边境政策中幸存下来
The Lancet Pub Date : 2026-10-01 DOI: 10.1016/s0140-6736(26)01954-9
Julia Molins
{"title":"Surviving a migration journey and border policies in the central Mediterranean","authors":"Julia Molins","doi":"10.1016/s0140-6736(26)01954-9","DOIUrl":"https://doi.org/10.1016/s0140-6736(26)01954-9","url":null,"abstract":"","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"1 1","pages":"1294-1306"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149088659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of product safety and liability law in governing digital determinants of health 产品安全和责任法在管理健康数字决定因素方面的作用
The Lancet Pub Date : 2026-10-01 DOI: 10.1016/s0140-6736(26)01986-0
Mindy Nunez Duffourc
{"title":"The role of product safety and liability law in governing digital determinants of health","authors":"Mindy Nunez Duffourc","doi":"10.1016/s0140-6736(26)01986-0","DOIUrl":"https://doi.org/10.1016/s0140-6736(26)01986-0","url":null,"abstract":"","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149088662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distinguishing AYA oncology from early-onset cancer 鉴别AYA肿瘤与早发性癌症
The Lancet Pub Date : 2026-10-01 DOI: 10.1016/s0140-6736(26)01828-3
Olga Husson,Winette van der Graaf
{"title":"Distinguishing AYA oncology from early-onset cancer","authors":"Olga Husson,Winette van der Graaf","doi":"10.1016/s0140-6736(26)01828-3","DOIUrl":"https://doi.org/10.1016/s0140-6736(26)01828-3","url":null,"abstract":"","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"36 1","pages":"1310"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149088655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in primary sclerosing cholangitis care – Authors' reply 原发性硬化性胆管炎的治疗进展——作者回复
The Lancet Pub Date : 2026-10-01 DOI: 10.1016/s0140-6736(26)01802-7
Annika Bergquist,Erik von Seth,Tom H Karlsen,Atsushi Tanaka,Cyriel Ponsioen
{"title":"Advances in primary sclerosing cholangitis care – Authors' reply","authors":"Annika Bergquist,Erik von Seth,Tom H Karlsen,Atsushi Tanaka,Cyriel Ponsioen","doi":"10.1016/s0140-6736(26)01802-7","DOIUrl":"https://doi.org/10.1016/s0140-6736(26)01802-7","url":null,"abstract":"","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"25 1","pages":"1311-1312"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149088656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Governing the digital determinants of health for children and young people: a global public health imperative 管理儿童和青年健康的数字决定因素：全球公共卫生的当务之急
The Lancet Pub Date : 2026-10-01 DOI: 10.1016/s0140-6736(26)01293-6
Barbara Prainsack,Rohinton P Medhora,Ilona Kickbusch
{"title":"Governing the digital determinants of health for children and young people: a global public health imperative","authors":"Barbara Prainsack,Rohinton P Medhora,Ilona Kickbusch","doi":"10.1016/s0140-6736(26)01293-6","DOIUrl":"https://doi.org/10.1016/s0140-6736(26)01293-6","url":null,"abstract":"","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149088657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral arterial disease: counting what matters 外周动脉疾病：计算重要因素
The Lancet Pub Date : 2026-10-01 DOI: 10.1016/s0140-6736(26)01985-9
The Lancet
{"title":"Peripheral arterial disease: counting what matters","authors":"The Lancet","doi":"10.1016/s0140-6736(26)01985-9","DOIUrl":"https://doi.org/10.1016/s0140-6736(26)01985-9","url":null,"abstract":"","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"19 1","pages":"1275"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149088661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiometabolic disease: the role of internal medicine 心脏代谢疾病：内科的作用
The Lancet Pub Date : 2026-10-01 DOI: 10.1016/s0140-6736(26)01827-1
Carlos Guijarro,Pablo Pérez-Martínez
{"title":"Cardiometabolic disease: the role of internal medicine","authors":"Carlos Guijarro,Pablo Pérez-Martínez","doi":"10.1016/s0140-6736(26)01827-1","DOIUrl":"https://doi.org/10.1016/s0140-6736(26)01827-1","url":null,"abstract":"","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"37 1","pages":"1309-1310"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149092355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The digital determinants of health: a new era for global public health 健康的数字决定因素：全球公共卫生的新时代
The Lancet Pub Date : 2026-10-01 DOI: 10.1016/s0140-6736(26)01292-4
James Shaw,Nicole Gross,Abril Saldaña-Tejeda,Caesar Atuire,Barbara Prainsack,Louise Holly,Ilona Kickbusch
{"title":"The digital determinants of health: a new era for global public health","authors":"James Shaw,Nicole Gross,Abril Saldaña-Tejeda,Caesar Atuire,Barbara Prainsack,Louise Holly,Ilona Kickbusch","doi":"10.1016/s0140-6736(26)01292-4","DOIUrl":"https://doi.org/10.1016/s0140-6736(26)01292-4","url":null,"abstract":"","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149088650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
8 weeks versus 12 weeks of sofosbuvir–velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India 8周vs 12周sofosbuvir-velpatasvir治疗初治、非肝硬化慢性丙型肝炎（RESOLVE）：印度的一项多中心、开放标签、非效性、随机对照试验
The Lancet Pub Date : 2026-09-30 DOI: 10.1016/s0140-6736(26)01380-2
Amit Goel DM, Sumit Rungta DM, Vinod Kumar DM, Shalimar DM, Ajay Kumar DM, Harshita Katiyar MSc, Surender Singh DM, Amar Deep PhD, Ajay Kumar Mishra DM, Ashish Awasthi PhD, Vikasendu Agarwal MD, Anurag Kumar Tiwari DM, Dawesh Prakash Yadav DM, Sunit Kumar Shukla DM, Ujjwal Sonika DM, Radha Krishan Dhiman DM, Bharat Bhushan Rewari MD, Prof Rakesh Aggarwal DM
{"title":"8 weeks versus 12 weeks of sofosbuvir–velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India","authors":"Amit Goel DM, Sumit Rungta DM, Vinod Kumar DM, Shalimar DM, Ajay Kumar DM, Harshita Katiyar MSc, Surender Singh DM, Amar Deep PhD, Ajay Kumar Mishra DM, Ashish Awasthi PhD, Vikasendu Agarwal MD, Anurag Kumar Tiwari DM, Dawesh Prakash Yadav DM, Sunit Kumar Shukla DM, Ujjwal Sonika DM, Radha Krishan Dhiman DM, Bharat Bhushan Rewari MD, Prof Rakesh Aggarwal DM","doi":"10.1016/s0140-6736(26)01380-2","DOIUrl":"https://doi.org/10.1016/s0140-6736(26)01380-2","url":null,"abstract":"Chronic hepatitis C virus (HCV) infection without cirrhosis can be treated with 12 weeks of sofosbuvir–velpatasvir combination therapy. We aimed to assess whether a shorter 8-week treatment regimen of this combination was non-inferior to the standard 12-week regimen in successfully clearing HCV infection in HCV-infected patients without evidence of cirrhosis.","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149087152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial orforglipron与甘精胰岛素在心血管风险增加的成人2型糖尿病患者中的心血管安全性（ACHIEVE-4）：一项事件驱动、随机、开放标签、非劣效性、主动比较试验
The Lancet Pub Date : 2026-09-30 DOI: 10.1016/s0140-6736(26)01865-9
Klara R Klein MD, Prof Carol Wysham MD, Prof Katherine R Tuttle MD, Prof Melanie J Davies MD, David Cox PhD, Jiaxun Chen PhD, Wen-Shuo Wu MD, Max Denning MD, Rong Liu PhD, Lisa Ludwig PharmD, Eric R Meskimen BA
{"title":"Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial","authors":"Klara R Klein MD, Prof Carol Wysham MD, Prof Katherine R Tuttle MD, Prof Melanie J Davies MD, David Cox PhD, Jiaxun Chen PhD, Wen-Shuo Wu MD, Max Denning MD, Rong Liu PhD, Lisa Ludwig PharmD, Eric R Meskimen BA","doi":"10.1016/s0140-6736(26)01865-9","DOIUrl":"https://doi.org/10.1016/s0140-6736(26)01865-9","url":null,"abstract":"Orforglipron is an oral, non-peptide GLP-1 receptor agonist. While some peptide GLP-1 receptor agonists have established cardiovascular benefit, the cardiovascular safety of non-peptide GLP-1 receptor agonists has not been studied. This study aimed to compare the effect of orforglipron with insulin glargine on the incidence of major adverse cardiovascular events in individuals with type 2 diabetes and obesity or overweight who are at increased risk for cardiovascular events.","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149087151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书